189 related articles for article (PubMed ID: 29428829)
1. A sensitive and selective ELISA methodology quantifies a demyelination marker in experimental and clinical samples.
Remacle AG; Dolkas J; Angert M; Hullugundi SK; Chernov AV; Jones RCW; Shubayev VI; Strongin AY
J Immunol Methods; 2018 Apr; 455():80-87. PubMed ID: 29428829
[TBL] [Abstract][Full Text] [Related]
2. Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis.
Belogurov AA; Kurkova IN; Friboulet A; Thomas D; Misikov VK; Zakharova MY; Suchkov SV; Kotov SV; Alehin AI; Avalle B; Souslova EA; Morse HC; Gabibov AG; Ponomarenko NA
J Immunol; 2008 Jan; 180(2):1258-67. PubMed ID: 18178866
[TBL] [Abstract][Full Text] [Related]
3. Immunodominant fragments of myelin basic protein initiate T cell-dependent pain.
Liu H; Shiryaev SA; Chernov AV; Kim Y; Shubayev I; Remacle AG; Baranovskaya S; Golubkov VS; Strongin AY; Shubayev VI
J Neuroinflammation; 2012 Jun; 9():119. PubMed ID: 22676642
[TBL] [Abstract][Full Text] [Related]
4. High levels of cerebrospinal fluid IgM binding to myelin basic protein are associated with early benign course in multiple sclerosis.
Annunziata P; Pluchino S; Martino T; Guazzi G
J Neuroimmunol; 1997 Jul; 77(1):128-33. PubMed ID: 9209277
[TBL] [Abstract][Full Text] [Related]
5. An extensive search for autoantibodies to myelin basic protein in cerebrospinal fluid of non-multiple-sclerosis patients: implications for the pathogenesis of multiple sclerosis.
Warren KG; Catz I
Eur Neurol; 1999; 42(2):95-104. PubMed ID: 10473981
[TBL] [Abstract][Full Text] [Related]
6. Anti-S-nitrosocysteine antibodies are a predictive marker for demyelination in experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
Boullerne AI; Rodriguez JJ; Touil T; Brochet B; Schmidt S; Abrous ND; Le Moal M; Pua JR; Jensen MA; Mayo W; Arnason BG; Petry KG
J Neurosci; 2002 Jan; 22(1):123-32. PubMed ID: 11756495
[TBL] [Abstract][Full Text] [Related]
7. B-cell responses to myelin basic protein and its epitopes in autoimmune encephalomyelitis induced by Semple rabies vaccine.
Piyasirisilp S; Hemachudha T; Griffin DE
J Neuroimmunol; 1999 Aug; 98(2):96-104. PubMed ID: 10430042
[TBL] [Abstract][Full Text] [Related]
8. An IgM anti-MBP Ab in a case of Waldenstrom's macroglobulinemia with polyneuropathy expressing an idiotype reactive with an MBP epitope immunodominant in MS and EAE.
Noerager BD; Inuzuka T; Kira J; Blalock JE; Whitaker JN; Galin FS
J Neuroimmunol; 2001 Feb; 113(1):163-9. PubMed ID: 11137588
[TBL] [Abstract][Full Text] [Related]
9. A rapid ELISA-based serum assay for myelin basic protein in multiple sclerosis.
Chamczuk AJ; Ursell M; O'Connor P; Jackowski G; Moscarello MA
J Immunol Methods; 2002 Apr; 262(1-2):21-7. PubMed ID: 11983216
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal synthesis of anti-myelin basic protein IgG in HIV-1+ patients.
Maimone D; Annunziata P; Cioni C; Leonardi A; Guazzi GC
Acta Neurol Scand; 1994 Oct; 90(4):285-92. PubMed ID: 7530889
[TBL] [Abstract][Full Text] [Related]
11. Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions.
O'Connor KC; Chitnis T; Griffin DE; Piyasirisilp S; Bar-Or A; Khoury S; Wucherpfennig KW; Hafler DA
J Neuroimmunol; 2003 Mar; 136(1-2):140-8. PubMed ID: 12620653
[TBL] [Abstract][Full Text] [Related]
12. Recombinant forms of myelin antigens expressed on Chinese hamster ovary (CHO) cells as a tool for identification of autoantibodies in serum of multiple sclerosis patients.
Jaśkiewicz E; Michałowska-Wender G; Pyszczek A; Wender M
Folia Neuropathol; 2010; 48(1):45-8. PubMed ID: 20383810
[TBL] [Abstract][Full Text] [Related]
13. Spinal activity of interleukin 6 mediates myelin basic protein-induced allodynia.
Ko JS; Eddinger KA; Angert M; Chernov AV; Dolkas J; Strongin AY; Yaksh TL; Shubayev VI
Brain Behav Immun; 2016 Aug; 56():378-89. PubMed ID: 26970355
[TBL] [Abstract][Full Text] [Related]
14. Kinetic profiles of cerebrospinal fluid anti-MBP in response to intravenous MBP synthetic peptide DENP(85)VVHFFKNIVTP(96)RT in multiple sclerosis patients.
Warren KG; Catz I
Mult Scler; 2000 Oct; 6(5):300-11. PubMed ID: 11064438
[TBL] [Abstract][Full Text] [Related]
15. Optic neuritis anti-myelin basic protein synthetic peptide specificity.
Warren KG; Catz I; Shutt K
J Neurol Sci; 1992 May; 109(1):88-95. PubMed ID: 1381412
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic effect of encapsulated into the nanocontainers MBP immunodominant peptides on EAE development in DA rats].
Stepanov AV; Belogurov AA; Mamedov AÉ; Melamed D; Smirnov IV; Kuzina ES; Genkin DD; Boĭko AN; Sharanova SN; Bacon A; Ponomarenko NA; Gabibov AG
Bioorg Khim; 2012; 38(3):306-14. PubMed ID: 22997702
[TBL] [Abstract][Full Text] [Related]
17. Autoantigen microarrays reveal myelin basic protein autoantibodies in morphea.
Zhu JL; Paniagua RT; Chen HW; Florez-Pollack S; Kunzler E; Teske N; Rainwater YB; Li QZ; Hosler GA; Li W; Ramirez DMO; Monson NL; Jacobe HT
J Transl Med; 2022 Jan; 20(1):41. PubMed ID: 35073943
[TBL] [Abstract][Full Text] [Related]
18. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T
Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390
[TBL] [Abstract][Full Text] [Related]
19. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
Vanderlugt CL; Neville KL; Nikcevich KM; Eagar TN; Bluestone JA; Miller SD
J Immunol; 2000 Jan; 164(2):670-8. PubMed ID: 10623809
[TBL] [Abstract][Full Text] [Related]
20. Reciprocal relationship between membrane type 1 matrix metalloproteinase and the algesic peptides of myelin basic protein contributes to chronic neuropathic pain.
Hong S; Remacle AG; Shiryaev SA; Choi W; Hullugundi SK; Dolkas J; Angert M; Nishihara T; Yaksh TL; Strongin AY; Shubayev VI
Brain Behav Immun; 2017 Feb; 60():282-292. PubMed ID: 27833045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
